Skip to content

908 Devices MASS Business Segments — Sales & Marketing

Similar metrics at other companies

Theravance Biopharma logo
TBPHSingle Reportable — Sales & Marketing
$6.91M-5.4%
Iovance Biotherapeutics, Inc. logo
IOVASingle Reportable — Sales & Marketing
$15.12M+13.2%
Merit Medical Systems logo
MMSISingle Reportable — Sales & Marketing
$73.96M+13.9%
Vertex, Inc. logo
VERXSingle Reportable — Sales & Marketing
$52.64M+9.3%
Axcelis Technologies logo
ACLSSingle Reportable — Sales & Marketing
$17.35M+14.7%
Boot Barn Holdings logo
BOOTSingle Reportable — Sales & Marketing
$103.9M+22.9%

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's business segments — sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's business segments — sales & marketing?
908 Devices (MASS) reported business segments — sales & marketing of $4.27M in Q1 2026.
How has 908 Devices's business segments — sales & marketing changed year-over-year?
908 Devices's business segments — sales & marketing decreased by 12.5% year-over-year, from $4.88M to $4.27M.
What is the long-term trend for 908 Devices's business segments — sales & marketing?
Over 2 years (2023 to 2025), 908 Devices's business segments — sales & marketing has grown at a -20.1% compound annual growth rate (CAGR), from $28.22M to $18.03M.
What does business segments — sales & marketing mean?
This metric measures the costs associated with promoting, selling, and distributing the company's products to its target markets in life sciences and industrial biotech. It reflects the company's investment in customer acquisition and market penetration strategies. Changes in this expense often correlate with the company's efforts to scale its commercial footprint and drive top-line growth.